Real-World Data on Attention Deficit Hyperactivity Disorder Medication Side Effects

| April 30, 2010 | 0 Comments

by Elisa Cascade; Amir H. Kalali, MD; and Sharon B. Wigal, PhD
Ms. Cascade is Vice President, Quintiles Inc./iGuard, Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic Group Leader CNS, Quintiles, Inc., and Professor of Psychiatry, University of California, San Diego, California; and Dr. Wigal is Clinical Professor of Pediatrics University of California; Irvine Director of Clinical Trials, Child Development Center, Irvine, California.

Psychiatry (Edgemont) 2010;7(4):13–15

The content you are trying to view is restricted to registered members only.
Membership to Innovations in Clinical Neuroscience is free, so please consider becoming a member today.
Thank you
ICNS Online Editor
Please Login or Register for access.

Tags: , , , , , , , ,

Category: Attention Deficit Hyperactivity Disorder, Child Adol Mental Disorders, Neurology, Psychiatry, Psychopharmacology, Sleep Disorders, Trend Watch

Leave a Reply